At a glance
- Originator Yamanouchi
- Class Antihyperglycaemics
- Mechanism of Action Glucose stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Type 2 diabetes mellitus
Most Recent Events
- 25 Aug 2003 No development reported - Preclinical for Type-2 diabetes mellitus in Japan (unspecified route)
- 30 Nov 2001 Preclinical development for Type-2 diabetes mellitus in Japan (Unknown route)